期刊文献+

VIL-10下调鼻咽癌细胞TAP-1基因表达的研究 被引量:3

Down-regulation of the expression of TAP-1 by VIL-10
下载PDF
导出
摘要 目的研究VIL-10对鼻咽癌细胞株TAP-1表达的影响。方法收集在不同时间不同浓度VIL-10处理的鼻咽癌细胞,RT-PCR检测TAP-1的表达。结果①10 ng/mlVIL-10处理的CNE-1、CNE-2和N-2-BMI-1细胞株在24、48 h时TAP-1表达无明显变化;②100 ng/ml VIL-10处理的CNE-1、CNE-2和N-2-BMI-1细胞株在24 h时TAP-1表达明显减弱。结论 100 ng/ml VIL-10在24 h可明显抑制TAP-1表达,EB病毒在鼻咽癌免疫抑制过程中起一定作用。 OBJECTIVE To investigate the influence of VIL-10 on the expression of TAP-1 in NPC cell lines.METHODS The NPC cells were treated by different concentration of VIL-10,and then harvested on different time.The expression of TAP-1 was detected by RT-PCR.RESULTS The cell lines of CNE-1,CNE-2 and N-2-BMI-1 were treated by VIL-10 with the concentration 10ng/ml,and the expression of TAP-1 in the 3 cell lines were not changed significantly at 24 hours and 48 hours.When the 3 cell lines were treated by VIL-10 with the concentration 100 ng/ml,the expression of TAP-1 at 24 hours were significantly decreased,but that at 48 hours were not significantly decreased.CONCLUTION The expression of TAP-1 were inhibited by VIL-10 with the concentration 100 ng/ml at 24 hours in NPC cell lines.The results indicate that EB Virus could induce immunosuppression in NPC patients.
出处 《中国耳鼻咽喉头颈外科》 2012年第5期255-257,共3页 Chinese Archives of Otolaryngology-Head and Neck Surgery
基金 云南省社会发展科技计划(应用基础研究项目)(2009ZC119M) 2011年云南省卫生科技内设研究机构项目资助(2011WS0068) 云南省社会发展科技计划(应用基础研究重点项目)(2009CC026)联合资助
关键词 鼻咽肿瘤 载体蛋白质类 逆转录聚合酶链反应 疱疹病毒4型 病毒白介素-10 Nasopharyngeal Neoplasms Carrier Proteins Reverse Transcriptase Polymerase Chain Reaction Herpesvirus 4 Human virus interleukin-10
  • 相关文献

参考文献7

二级参考文献51

共引文献31

同被引文献58

  • 1任艳鑫,李晓江,杨洁,马静,赵留芳,喻博,王虎,孙强民,龙海庭,隋军.鼻咽癌组织中BCRF-1基因表达及其与免疫功能的相关性分析[J].西安交通大学学报(医学版),2012,33(4):474-477. 被引量:3
  • 2尹志华,蒋卫红,李峰,杨旭宇,冯湘玲,姚开泰.鼻咽癌组织中EB病毒潜伏相关基因的表达[J].中国病理生理杂志,2007,23(12):2374-2378. 被引量:6
  • 3Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion [ J ]. Science, 2011, 331(624) : 1565-1570. DOI: 10. l126/science. 1203486.
  • 4Chang CS, Chang JH, Hsu NC, et al costimulatory molecules are potential nasopharyngeal carcinoma [ J ]. BMC 10.1186/1471-2407-7-88. Expression of CDS0 and CD86 markers for better survival in Cancer, 2007, 7: 88. DOI:.
  • 5Ren SP, Wang L, Wang H, et al. Gene therapy for human nasopha-ryngeal carcinoma by adenovirus-mediated transfer of human p53, GM-CSF, and B7-1 genes in a mouse xenograft tumor model [ J ]. Cancer Biother Radiopharm, 2008, 23 (5): 591-602. DOI: 10. 1089/ebr. 2007. 0447.
  • 6Connolly EC, Freimuth J, Akhurst RJ. Complexities of TGF-13 targe- ted cancer therapy[J]. Int J Biol Sci, 2012, 8(7) : 964-978. DOI: 10.7150/ijbs. 4564.
  • 7Hu S, Zhou G, Zhang L, et al. The effects of functional polymor- phisms in the TGF[31 gene on nasopharyngeal carcinoma susceptibili- ty[ J ]. Otolaryngol Head Neck Surg, 2012, 146 (4) : 579-584. DOI : 10.1177/0194599811434890.
  • 8Poh YW, Gan SY, Tan EL. Effects of IL-6, IL-10 and TGF-[3 on the expression of survivin and apoptosis in nasopharyngeal carcinoma TW01 cells[J]. Exp Oncol, 2012, 34(2) : 85-89.
  • 9Flies DB, Sandier BJ, Sznol M, et al. Blockade of the B7-H1/PD-1 pathway for cancer immunotherapy[ J ]. Yale J Biol Med, 2011, 84 (4) : 409-421.
  • 10Chen B J, Chapuy B, Ouyang J, et al. PD-L1 expression is charac- teristic of a subset of aggressive B-cell lymphomas and virus-associa- ted malignancies [ J]. Clin Cancer Res, 2013, 19 ( 13 ) : 3462- 3473. DOI: 10. 1158/1078-0432. CCR-13-0855.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部